- $16.6 BnWorld market, 2023
- $131.6 BnProjected, 2033
- 23%Growth a year (CAGR)
- –Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$7 Bn
21% a year · 42% of the world -
2
China
$1.3 Bn
24.5% a year · 8% of the world -
3
Canada
$1.3 Bn
23% a year · 8% of the world -
4
Japan
$1 Bn
23.5% a year · 6.2% of the world -
5
Germany
$608 Mn
21.2% a year · 3.7% of the world -
6
France
$457 Mn
22% a year · 2.8% of the world -
7
UK
$432 Mn
21% a year · 2.6% of the world -
8
Brazil
$415 Mn
24% a year · 2.5% of the world -
9
Italy
$398 Mn
22.5% a year · 2.4% of the world -
10
Ecuador
$332 Mn
23.6% a year · 2% of the world
Cell Based Immunotherapy by country and region
Spain
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Egypt
Philippines
Malaysia
Hong Kong
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 21,017 papers since 2021
- Nanotechnology-enabled drug delivery for retinoblastoma: formulation strategies, ocular targeting and translational perspectives. Nanomedicine (London, England), 2026
- Next-generation CAR-NK therapies: molecular engineering strategies for solid tumors. Cellular immunology, 2026
- Senescence-targeted engineered CAR-T immunotherapy: advances, challenges and perspectives for engineered senolytic immunotherapy. EBioMedicine, 2026
- Terminal differentiation program of CD8 T cells guides immunotherapeutic options for CLL patients. Blood, 2026
- Arrival of CAR T-Cell Therapies for Stiff Person Syndrome. JAMA neurology, 2026
Compare Cell Based Immunotherapy side by side
Key companies in Cell Based Immunotherapy
Novartis AG
Gilead Sciences, Inc.
AbbVie
Bristol-Myers Squibb
Quick answers
How big is the Cell Based Immunotherapy market?
The world Cell Based Immunotherapy market was worth about $16.6 Bn in 2023 and is projected to reach $131.6 Bn by 2033, growing 23% a year (CAGR).
Which country has the largest Cell Based Immunotherapy market?
The US is the largest of the 24 countries we cover, at $7 Bn in 2023. India grows fastest, at 26% a year.
How much research is published on Cell Based Immunotherapy?
PubMed lists about 21,017 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.